Clinical trials
Recruiting Bronchiectasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 15 |
| 2025 | 23 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 62 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 7 |
| First Affiliated Hospital of Ningbo University | 4 |
| Shanghai Pulmonary Hospital, Shanghai, China | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
| CHU de Reims | 2 |
| Imperial College London | 2 |
| Qianfoshan Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Seoul National University Hospital | 2 |
| University College, London | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiectasis | 62 |
| Pulmonary Disease, Chronic Obstructive | 18 |
| Asthma | 13 |
| Cystic Fibrosis | 6 |
| Lung Diseases, Interstitial | 5 |
| Lung Neoplasms | 4 |
| Ciliary Motility Disorders | 3 |
| Disease | 3 |
| Pseudomonas Infections | 3 |
| Aspergillosis, Allergic Bronchopulmonary | 2 |
Trials
Showing 76 to 62 of 62. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.